Veracyte
VCYT
235 hedge funds and large institutions have $3.92B invested in Veracyte in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 93 increasing their positions, 77 reducing their positions, and 27 closing their positions.
789% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $1.47M
52% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 27
23% more capital invested
Capital invested by funds: $3.2B → $3.92B (+$722M)
21% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 77
6% more funds holding
Funds holding: 222 → 235 (+13)
4.02% less ownership
Funds ownership: 113.09% → 109.07% (-4%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$171M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$126M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$66.9M |
| 4 |
BlackRock
New York
|
+$49.8M |
| 5 |
Jennison Associates
New York
|
+$42.6M |
Top Sellers
VCYT Hedge Fund Activity: Q1 2021 in Review
235 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2021, worth a combined $3.92B — up 23% from $3.2B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new VCYT positions and 27 closed out — a net gain of 14 holders — while 93 added to existing stakes and 77 trimmed.
The largest buyer was Matrix Capital Management Company, opening a new position worth an estimated $171M. The largest seller was ARK Investment Management, cutting an estimated $81.2M.
- 235 institutional investors held Veracyte (VCYT) as of Q1 2021, up from 222 in Q4 2020.
- Funds reported $3.92B of Veracyte stock for Q1 2021, up 23% quarter-over-quarter.
- 41 funds opened new Veracyte positions in Q1 2021 and 27 closed out, a net change of +14 holders.
- The largest Veracyte buyer in Q1 2021 was Matrix Capital Management Company, an estimated $171M added.
- The largest Veracyte seller in Q1 2021 was ARK Investment Management, an estimated $81.2M sold.
Based on aggregated 13F filings for Q1 2021.